Interviews & Media

American Journal of Managed Care: Center for Biosimilars

Part 1: Unlocking the Potential of Biosimilars to Improve Health Equity

Healio 

Drug Costs and Nocebo Risks: Navigating the Humira 'Biosimilar Boom' 1 Year Later

Healio

Satisfaction Low with Mandatory Transition from Humira to Biosimilar in New Zealand

Consultant Live

Breaking Down Barriers: Why Biosimilars Face Resistance in the US Market

American Journal of Managed Care: Center for Biosimilars

Study Documents HCPs' Experiences of a Mandatory Switch to Inform Future Transitions

U.S. Pharmacist

Fostering the Adoption of Biosimilars Into Clinical Practice

HCP Live

Patients Unsatisfied After Mandatory Adalimumab Biosimilar Transition

Consultant Live

Providers Express Difficulties in Transitioning to Biosimilars